Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Biotechnology. Regulating gene drives.

Oye KA, Esvelt K, Appleton E, Catteruccia F, Church G, Kuiken T, Lightfoot SB, McNamara J, Smidler A, Collins JP.

Science. 2014 Aug 8;345(6197):626-8. doi: 10.1126/science.1254287. Epub 2014 Jul 17. No abstract available.

PMID:
25035410
[PubMed - in process]
2.

Evaluation of (99m)Tc-Probestin SPECT As a Novel Technique for Noninvasive Imaging of Kidney Aminopeptidase N Expression.

Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD Jr, Rao CV, Gali H.

Mol Pharm. 2014 Aug 4;11(8):2948-53. doi: 10.1021/mp5002872. Epub 2014 Jul 10.

PMID:
24988047
[PubMed - in process]
3.

Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL-22 binding protein.

Janakiram NB, Mohammed A, Bryant T, Brewer M, Biddick L, Lightfoot S, Lang ML, Rao CV.

Mol Carcinog. 2014 May 5. doi: 10.1002/mc.22168. [Epub ahead of print]

PMID:
24797894
[PubMed - as supplied by publisher]
4.

Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.

Madka V, Mohammed A, Li Q, Zhang Y, Patlolla JM, Biddick L, Lightfoot S, Wu XR, Steele V, Kopelovich L, Rao CV.

Cancer Prev Res (Phila). 2014 Jul;7(7):708-16. doi: 10.1158/1940-6207.CAPR-14-0087. Epub 2014 May 2.

PMID:
24795386
[PubMed - in process]
5.

Distinguishing patients with stage I lung cancer versus control individuals using serum mass profiling.

Hanas JS, Peyton MD, Lerner MR, Lightfoot SA, Deb SJ, Hanas RJ, Vu NT, Kupiec TC, Stowell DE, Brackett DJ, Dubinett SM, Hocker JR.

Cancer Invest. 2014 May;32(4):136-43. doi: 10.3109/07357907.2014.883528. Epub 2014 Feb 28.

PMID:
24579933
[PubMed - indexed for MEDLINE]
6.

Insulin exerts direct effects on carcinogenic transformation of human endometrial organotypic cultures.

Bishop EA, Lightfoot S, Thavathiru E, Benbrook DM.

Cancer Invest. 2014 Mar;32(3):63-70. doi: 10.3109/07357907.2013.877479.

PMID:
24499106
[PubMed - indexed for MEDLINE]
7.

Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.

Mohammed A, Janakiram NB, Brewer M, Ritchie RL, Marya A, Lightfoot S, Steele VE, Rao CV.

Transl Oncol. 2013 Dec 1;6(6):649-59. eCollection 2013 Dec 1.

PMID:
24466367
[PubMed]
Free PMC Article
8.

Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.

Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV.

Cancer Prev Res (Phila). 2014 Mar;7(3):300-9. doi: 10.1158/1940-6207.CAPR-13-0345. Epub 2014 Jan 15.

PMID:
24431404
[PubMed - in process]
9.

Colon Macrophages Polarized by Commensal Bacteria Cause Colitis and Cancer through the Bystander Effect.

Yang Y, Wang X, Huycke T, Moore DR, Lightfoot SA, Huycke MM.

Transl Oncol. 2013 Oct 1;6(5):596-606. eCollection 2013.

PMID:
24151540
[PubMed]
Free PMC Article
10.

Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury.

May R, Qu D, Weygant N, Chandrakesan P, Ali N, Lightfoot SA, Li L, Sureban SM, Houchen CW.

Stem Cells. 2014 Mar;32(3):822-7. doi: 10.1002/stem.1566.

PMID:
24123696
[PubMed - in process]
11.

Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.

Janakiram NB, Mohammed A, Zhang Y, Brewer M, Bryant T, Lightfoot S, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2013 Dec;6(12):1251-61. doi: 10.1158/1940-6207.CAPR-13-0249. Epub 2013 Sep 30.

PMID:
24080207
[PubMed - indexed for MEDLINE]
12.

DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.

Sureban SM, May R, Qu D, Weygant N, Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG, Houchen CW.

PLoS One. 2013 Sep 9;8(9):e73940. doi: 10.1371/journal.pone.0073940. eCollection 2013.

PMID:
24040120
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Chemopreventive effects of the p53-modulating agents CP-31398 and Prima-1 in tobacco carcinogen-induced lung tumorigenesis in A/J mice.

Rao CV, Patlolla JM, Qian L, Zhang Y, Brewer M, Mohammed A, Desai D, Amin S, Lightfoot S, Kopelovich L.

Neoplasia. 2013 Sep;15(9):1018-27.

PMID:
24027427
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

β-Escin inhibits NNK-induced lung adenocarcinoma and ALDH1A1 and RhoA/Rock expression in A/J mice and growth of H460 human lung cancer cells.

Patlolla JM, Qian L, Biddick L, Zhang Y, Desai D, Amin S, Lightfoot S, Rao CV.

Cancer Prev Res (Phila). 2013 Oct;6(10):1140-9. doi: 10.1158/1940-6207.CAPR-13-0216. Epub 2013 Aug 20.

PMID:
23963803
[PubMed - indexed for MEDLINE]
15.

p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.

Madka V, Zhang Y, Li Q, Mohammed A, Sindhwani P, Lightfoot S, Wu XR, Kopelovich L, Rao CV.

Neoplasia. 2013 Aug;15(8):966-74.

PMID:
23908596
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

He T, Smith N, Saunders D, Pittman BP, Lerner M, Lightfoot S, Silasi-Mansat R, Lupu F, Towner RA.

Am J Nucl Med Mol Imaging. 2013 Jul 10;3(4):300-11. Print 2013.

PMID:
23901356
[PubMed]
Free PMC Article
17.

Brain injury: neuro-inflammation, cognitive deficit, and magnetic resonance imaging in a model of blast induced traumatic brain injury.

Tompkins P, Tesiram Y, Lerner M, Gonzalez LP, Lightfoot S, Rabb CH, Brackett DJ.

J Neurotrauma. 2013 Nov 15;30(22):1888-97. doi: 10.1089/neu.2012.2674. Epub 2013 Sep 17.

PMID:
23777197
[PubMed - indexed for MEDLINE]
18.

14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.

Oh S, Shin S, Lightfoot SA, Janknecht R.

Cancer Res. 2013 Aug 15;73(16):5110-9. doi: 10.1158/0008-5472.CAN-13-0578. Epub 2013 Jun 17.

PMID:
23774214
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.

Hocker JR, Mohammed A, Aston CE, Brewer M, Lightfoot SA, Rao CV, Hanas JS.

Int J Cancer. 2013 Dec 1;133(11):2662-71. doi: 10.1002/ijc.28285. Epub 2013 Jul 1.

PMID:
23712558
[PubMed - indexed for MEDLINE]
20.

Carriers of a novel frame-shift insertion in WNT16a possess elevated pancreatic expression of TCF7L2.

Howard EW, Been LF, Lerner M, Brackett D, Lightfoot S, Bullen EC, Sanghera DK.

BMC Genet. 2013 Apr 23;14:28. doi: 10.1186/1471-2156-14-28.

PMID:
23617586
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk